NovaBay Pharmaceuticals, Inc. - NBY
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Jun 17, 2026 | Chief Executive Officer | X | A | 11,332,020.0 | 0.0 | 0.0 | 0.0 | View | |
| Jun 17, 2026 | Chief Executive Officer | S | D | 24,720.0 | 1.09 | 26,944.8 | 22,668,516.0 | View | |
| Jun 17, 2026 | Chief Executive Officer | X | A | 11,332,020.0 | 0.0024 | 27,196.85 | 22,693,236.0 | View | |
| Jun 17, 2026 | — | X | A | 11,332,020.0 | 0.0 | 0.0 | 0.0 | View | |
| Jun 17, 2026 | — | S | D | 24,720.0 | 1.09 | 26,944.8 | 22,668,516.0 | View | |
| Jun 17, 2026 | — | X | A | 11,332,020.0 | 0.0024 | 27,196.85 | 22,693,236.0 | View | |
| Jun 17, 2026 | — | X | A | 11,332,020.0 | 0.0 | 0.0 | 0.0 | View | |
| Jun 17, 2026 | — | S | D | 24,720.0 | 1.09 | 26,944.8 | 22,668,516.0 | View | |
| Jun 17, 2026 | — | X | A | 11,332,020.0 | 0.0024 | 27,196.85 | 22,693,236.0 | View | |
| May 19, 2026 | — | P | A | 50,109,253.0 | 0.85 | 42,592,865.05 | 50,109,253.0 | View | |
| May 19, 2026 | — | P | A | 53,679,974.0 | 0.85 | 45,627,977.9 | 53,679,974.0 | View | |
| May 19, 2026 | Chief Executive Officer | P | A | 53,679,974.0 | 0.85 | 45,627,977.9 | 53,679,974.0 | View |